Chemomab Therapeutics Ltd. (CMMB) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$1.05
—
Mkt Cap $12.31M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | — | — | — | -$0.20 | -$0.24 | -20.00% |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.20 | -$0.80 | -300.00% |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.80 | -$0.36 | +55.00% |
| Q2 2025 May 15, 2025 | — | — | — | -$0.20 | -$0.14 | +30.00% |
| Q1 2025 Mar 3, 2025 | — | — | — | -$0.20 | -$0.16 | +20.00% |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.20 | -$0.20 | +0.00% |
| Q3 2024 Aug 21, 2024 | — | — | — | -$0.20 | -$0.26 | -30.00% |
| Q2 2024 May 9, 2024 | — | — | — | -$0.20 | -$0.28 | -40.00% |
| Q1 2024 Mar 7, 2024 | — | — | — | -$0.40 | -$0.26 | +35.00% |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.60 | -$0.34 | +43.33% |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.80 | -$0.72 | +10.00% |
| Q2 2023 May 11, 2023 | — | — | — | -$0.80 | -$0.80 | +0.00% |
| Q1 2023 Mar 20, 2023 | — | — | — | -$0.80 | -$0.72 | +10.00% |
| Q4 2022 Nov 11, 2022 | — | — | — | -$0.60 | -$0.70 | -16.67% |
| Q3 2022 Aug 12, 2022 | — | — | — | -$0.60 | -$0.54 | +10.00% |
| Q2 2022 May 12, 2022 | — | — | — | -$0.40 | -$0.44 | -10.00% |
| Q1 2022 Mar 9, 2022 | — | — | — | -$0.40 | -$0.44 | -10.00% |
| Q4 2021 Nov 12, 2021 | — | — | — | -$0.14 | -$0.26 | -79.31% |
| Q3 2021 Aug 13, 2021 | — | — | — | -$0.12 | -$0.26 | -126.09% |
| Q2 2021 May 13, 2021 | — | — | — | -$0.43 | -$0.22 | +48.84% |
| Q1 2021 Mar 9, 2021 | — | — | — | — | -$0.05 | — |
| Q4 2020 Nov 16, 2020 | — | — | — | — | -$0.03 | — |
| Q3 2020 Aug 14, 2020 | — | — | — | — | -$0.03 | — |
| Q2 2020 May 7, 2020 | — | — | — | -$1.84 | -$8.00 | -334.78% |
| Q1 2020 Mar 17, 2020 | — | — | — | -$2.00 | $31.20 | +1660.00% |
| Q4 2019 Nov 15, 2019 | — | — | — | -$2.93 | -$34.40 | -1074.06% |
| Q3 2019 Aug 5, 2019 | — | — | — | -$2.64 | -$4.00 | -51.52% |
| Q2 2019 May 22, 2019 | — | — | — | -$2.56 | -$56.00 | -2087.50% |